November 6th news, at the 4th Jin Expo, Beijing Novartis AG Co., Ltd. Zero Krypton Technology and Novartis have reached strategic cooperation to create a digital medical innovation model.
#Linkdoc technology full
It is understood that the intention of cooperation between Zero Krypton and Merck & Co Inc China means that in the future, the two sides will give full play to their respective advantages in the fields of medicine and health and Internet medical care, and jointly explore Internet + Medical and Health in China. (hereinafter referred to as "Merck & Co Inc China") officially signed a memorandum of cooperation, demonstrating their intention to explore innovative ways of cooperation in the fields of patient health management, digital technology and digital pharmaceutical industry, so as to help the implementation of the "healthy China" strategy. (hereinafter referred to as "Zero Krypton Technology" or "Zero Krypton") and Merck & Co Inc (China) Investment Co., Ltd. November 8, Zero Krypton Technology (Tianjin) Co., Ltd. Zero Krypton Technology and Merck & Co Inc China have reached a cooperation to explore a new path of digital cooperation in the pharmaceutical industry. LinkDoc Technology Filed to Withdraw U.S. Reducing the marketing burden first is the right path. “They need to be assured that what happened to Didi won’t happen to them,” said Protiviti’s Pang.After reading the financial reports of more than 10 medical companies, are these the only 3 that can make money?
“Companies now feel vulnerable and exposed to different risks, including potentially damaging investor interests,” says Bruce Pang, head of macro and strategy research at China Renaissance Securities. As of Thursday, Didi had lost roughly $14 billion in value since it listed. The company is now trading at $11.21 per share, 21% below its offer price. “The companies are likely buying time to ensure that they’ve done enough due diligence that is required in this new Data Security Law era,” says Michael Pang, managing director at consulting firm Protiviti.Īnother concern is investor sentiment, given how badly Beijing’s surprise actions have hurt Didi’s stock. The string of shelved listings may indicate that companies are putting off IPOs until they better understand Beijing’s new regulatory scheme, including the State Council’s Tuesday directive on “illegal securities activities,” which the body has yet to clarify.
Soulgate cited “alternative financing options” as the reason for yanking its IPO. Bike-sharing app Hello and dating platform Soulgate both scrapped their Nasdaq listing plans in late June the companies were aiming to raise $100 million and $198 million, respectively. Then on Tuesday, China’s State Council announced stricter data supervision, particularly pertaining to “cross-border data flow…and the information security of overseas-listed companies,” a sweeping statement that indicated Beijing’s intention to more tightly regulate Chinese companies seeking to raise capital on foreign exchanges.Ĭhina’s most popular fitness app, Keep, which operates under parent group Beijing Calories Technology, was eyeing a $500 million NYSE listing, but didn’t follow through on the debut that was supposed to take place this week, the FT reports. The two companies went public in the U.S. The CAC announced on Monday two more probes, into Full Truck Alliance, known as China’s “ Uber for trucks,” and job recruitment platform Boss Zhipin, citing similar issues. Last week, the Cyberspace Administration of China (CAC) announced an investigation into Didi over data and national security concerns, two days after the ride-hailing giant raised $4.4 billion in an IPO on the New York Stock Exchange (NYSE). LinkDoc’s delay was the first sign that Beijing’s clampdown on Chinese companies’ overseas listings is stalling the parade of firms readying IPOs in the U.S. The Beijing-based company pulled the listing because of Beijing’s regulatory crackdown, says Reuters. pipeline among firms that had already filed to list, according to Refinitiv data. It was the second-largest Chinese IPO in the U.S. LinkDoc was expected to raise up to $211 million on the Nasdaq. Medical data platform LinkDoc Technology shelved its IPO plans on Thursday, becoming the first company to axe its debut after China announced stricter supervision on overseas listings, Bloomberg reports.
0 kommentar(er)
